Clinical trial
The Use of Metformin in Early Breast Cancer Patients Pre-Surgery: A Phase 0 Study Regarding The Biological Effect
NCT01302002 is registered in ClinicalTrials.gov with Instituto Nacional de Cancer, Brazil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Metformin in Early Breast Cancer Patients Pre-Surgery: A Phase 0 Study Regarding The Biological Effect
- Lead sponsor
- Instituto Nacional de Cancer, Brazil
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- January 31, 2011
- Completion date
- February 29, 2016
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer